Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma
1 Vues
• 07/17/23
0
0
Intégrer
administrator
Les abonnés
Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires